로딩 중…
지수 로딩 중…
Cogent Biosciences, Inc.
COGT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$34.54+2.58%
2026-06-18
Price Chart
Cogent Biosciences, Inc.+377.07%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $5.90B |
| Revenue | $0.00 |
| Net Income | $-354M |
| Total Assets | $903M |
| Net Assets | $608M |
| Value | |
| P/B | 9.71x |
| FCF Yield | -4.85% |
| Profitability | |
| ROE | -58.30% |
| ROA | -39.24% |
| Financial Health | |
| Debt Ratio | 48.60% |
| Total Debt | $239M |
| FCF | $-286M |
| Cash | $241M |
| Current Ratio | 15.14x |
| Performance | |
| 1Y Return | 377.07% |
| 1M Return | 10.53% |
| From 52W High | -21.02% |
| 1Y MDD | -26.34% |
| Trading | |
| Volume | 3,917,822 shares |
| Trading Value | $135M |
| Per Share | |
| EPS | $-4.87 |
| BPS | $9.41 |